Loading...

Artrya Limited

AYA.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.70
A$0.00(0.00%)

Artrya Limited (AYA.AX) Stock Overview

Explore Artrya Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.8/100

Key Financials

Market Cap90.3M
P/E Ratio-4.48
EPS (TTM)$-0.18
ROE-0.92%
Fundamental Analysis

AI Price Forecasts

1 Week$0.72
1 Month$0.72
3 Months$1.07
1 Year Target$1.52

AYA.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Artrya Limited (AYA.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.48 and a market capitalization of 90.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
0.00%
Profit Growth
A$-0.18
↓ 25.72%
EPS Growth
A$-0.18
↓ 28.57%
Operating Margin
-57825.48%
↓ 15.91%
ROE
-92.48%
↓ 25.72%
Dividend Yield
0.00%
Analyst Recommendations data is not available for AYA.AXAnalyst Recommendations details for AYA.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.

CEO

Mathew Regan

Headquarters

1257 Hay Street, West Perth, WA

Founded

2021

Frequently Asked Questions

;